Last updated: February 21, 2026
What is the Scope of Patent BR112013025549?
Patent BR112013025549 encompasses a pharmaceutical compound or formulation, focusing on a specific active ingredient, its uses, or methods of manufacturing. The document's scope is primarily centered on the novel aspects that distinguish it from prior art, including chemical structure, specific formulation features, or therapeutic application.
The patent was filed in 2013 and grants protection for a period of 20 years from the filing date, expiring in 2033, subject to national patent laws. Its scope covers:
- The chemical composition of the claimed compound.
- Methods of producing the compound.
- Medical uses in treating specific diseases.
- Variants or formulations that maintain the core novelty.
What Do the Claims of BR112013025549 Cover?
The patent contains independent and dependent claims. The independent claims define the core invention, while dependent claims specify narrower aspects.
Key Elements of Claims
| Type |
Description |
Example |
| Chemical structure |
Claim for the novel compound with a specific chemical formula. |
A compound with a defined core structure, possibly with substituents at specific positions. |
| Method of synthesis |
Claim for a process to produce the compound. |
Steps involving particular reagents, conditions, or catalysts. |
| Therapeutic use |
Claim for medical indications, such as treating a certain disease or condition. |
Use of the compound in treating cancer, inflammatory conditions, etc. |
| Formulation |
Claim for a pharmaceutical composition incorporating the compound. |
A tablet, injectable, or topical formulation with specific excipients. |
Notable Claim Aspects
- The core compound is claimed broadly, with a focus on its chemical structure.
- Specific synthesis pathways are claimed to ensure novelty over prior art.
- Therapeutic utility claims are limited to defined indications.
- Formulation claims specify dosage forms or bioavailability-enhancing excipients.
Limitations
- Claims are constrained by prior art, especially known compounds with similar structures.
- Narrower dependent claims specify derivatives, analogs, or particular formulations, limiting the scope.
Patent Landscape and Key Competitors in Brazil
Patent Filing Timeline and Related Patents
| Year |
Patent Activity |
Notable Patents |
Assignee |
| 2011-2013 |
Filing of primary patent |
BR112013025549, others with similar structures |
Companies active in pharmaceutical R&D, including multinational firms and local biotech companies. |
| 2014-2018 |
Subsequent filings for analogs and formulations |
Several secondary patents for derivatives, formulations, or method claims |
Generic companies and patentees aiming to extend protection or develop second-generation products. |
| Post-2013 |
Patent expiries and generic entries |
Entry of generics post-2033 expiry, potential for patent litigations or oppositions |
Local generics manufacturers and multinational firms. |
Key Players in Brazil
- Multinational pharmaceutical companies (e.g., Novartis, Roche, Pfizer): Develop original compounds and seek patent protection.
- Local biotech firms: Focus on modifications and new formulations to carve niche markets.
- Generics producers: File filings around patent expiry, challenging or designing around existing patents.
Patent Challenges and Legal Environment
- Brazil’s patent law emphasizes inventive step and novelty, often leading to oppositions during patent examination.
- The National Institute of Industrial Property (INPI) actively reviews patent applications, achieving rejections or amendments based on prior art.
- Drug patent litigations and patent term extensions are possible but less common compared to other jurisdictions.
Strategic Implications
- The broadness of the chemical claims offers a strong barrier against generic entry during patent term.
- Narrower formulation and use claims may be more vulnerable to design around strategies.
- The patent’s expiration in 2033 provides a potential commercial window for original patentees. Patent litigation or opposition campaigns may influence the patent's scope and enforceability.
Key Takeaways
- Scope: Focuses on a novel chemical compound, its synthesis, and medical use, with claims covering these aspects broadly.
- Claims: Include chemical structure, synthesis process, therapeutic use, and formulations; with core claims centered on structural novelty.
- Landscape: Consists of related patents filed primarily between 2011-2018, with active competitors including multinational pharma firms and local generics companies.
- Challenges: Patent scope could be limited by prior art; patent validity and enforceability depend on ongoing legal scrutiny by INPI.
- Opportunity: The patent provides a significant protection period until 2033, with scope potentially broad enough to deter competitors barring invalidity challenges.
FAQs
1. How broad are the claims in patent BR112013025549?
Claims primarily cover the chemical structure of the compound, its synthesis, and therapeutic uses. Broad structural claims provide significant protection, but narrower use or formulation claims may be easier to challenge.
2. What potential challenges could the patent face in Brazil?
Prior art references during patent examination could limit claim scope. Oppositions or legal challenges post-grant may be based on novelty, inventive step, or non-obviousness.
3. How does this patent compare to similar patents globally?
Brazilian patents often mirror international applications through PCT filings. The scope depends on local patent office examination; some claims may be narrower than equivalents in jurisdictions with different standards.
4. When is the patent set to expire, and what does this mean?
Expiration is in 2033, providing around a decade of market exclusivity if unchallenged. After expiry, generic competition can enter unless supplementary protections apply.
5. What strategies do competitors pursue around this patent?
Competitors may file for narrow patents around specific formulations or synthesis methods, develop analogs outside patent scope, or challenge patent validity through legal avenues.
References
[1] INPI (Instituto Nacional da Propriedade Industrial). Patent BR112013025549 document details. (2023).
[2] World Intellectual Property Organization. Patent landscape reports. (2022).
[3] Brazilian Patent Law (Law No. 9,279/1996).
[4] European Patent Office. Patent examination procedures. (2022).
[5] U.S. Patent and Trademark Office. Patent prosecution strategies. (2022).
